What one share of Park Ha Biological Technology Co. holds
Our “Park Ha” brand focuses on providing solutions for problematic skin. Established in 2016, the brand had its first store launched in 2017. In addition to the five stores directly operated by Park Ha Jiangsu, as of October 31, 2025, 2024 and 2023, we had
Park Ha Biological Technology Co.’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-10-31; the balance sheet is as of 2025-10-31.
| Sales | $4.29 |
|---|---|
| Profit | −$41.38 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | −$0.01 |
| Cash and investments | $6.43 |
| Book value | $6.78 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $4.92 | $1.70 | $0.05 | $0.21 | — | $2.02 |
| 2024 | $4.76 | $0.96 | $0.17 | $1.75 | — | $3.01 |
| 2025 | $4.29 | −$41.38 | $0.15 | −$0.01 | — | $6.78 |
Common questions about Park Ha Biological Technology Co.
How much does one share of Park Ha Biological Technology Co. earn?
Over its latest fiscal year, Park Ha Biological Technology Co. lost $41.38 for each share on $4.29 of sales.
Does Park Ha Biological Technology Co. pay a dividend?
Park Ha Biological Technology Co. didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Park Ha Biological Technology Co.’s book value per share?
Park Ha Biological Technology Co.’s book value is $6.78 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of October 31, 2025.
How much cash and debt does each share of Park Ha Biological Technology Co. have?
Each share of Park Ha Biological Technology Co. has $6.43 of cash and investments, as of October 31, 2025.
What is Park Ha Biological Technology Co.’s free cash flow per share?
−$0.01 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.